Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
bispecific antibodies
Fierce Pharma
Summit in high-stakes deal talks with AstraZeneca: Bloomberg
After several PD-1xVEGF competitors forged alliances with Big Pharma, Summit is reportedly seeking its own deal.
Angus Liu
Jul 7, 2025 10:45am
Biokin, having landed BMS deal, posts ph. 3 bispecific ADC win
Jul 2, 2025 9:53am
Sanofi takes up option on Adagene bispecific, invests $25M
Jul 1, 2025 8:10am
Pfizer CEO makes case for $6B bet on 'fabulous' bispecific
Jun 10, 2025 9:56am
Are Lilly, Novartis eyeing the PD-1xVEGF field? Execs weigh in
Jun 4, 2025 1:00pm
J&J shares survival data on KLK2 bispecific in prostate cancer
Jun 2, 2025 6:40am